Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Other financing activities (2016 - 2022)

Bio-Techne has reported Other financing activities over the past 14 years, most recently at -$2.5 million for Q3 2022.

  • For Q3 2022, Other financing activities fell 113.43% year-over-year to -$2.5 million; the TTM value through Jun 2023 reached -$2.5 million, down 108.84%, while the annual FY2023 figure was -$2.5 million, 411.8% down from the prior year.
  • Other financing activities for Q3 2022 was -$2.5 million at Bio-Techne, down from $3.4 million in the prior quarter.
  • Over five years, Other financing activities peaked at $18.3 million in Q3 2021 and troughed at -$4.9 million in Q3 2020.
  • A 5-year average of $3.5 million and a median of $2.8 million in 2019 define the central range for Other financing activities.
  • Biggest five-year swings in Other financing activities: plummeted 2437.21% in 2018 and later skyrocketed 1133.33% in 2019.
  • Year by year, Other financing activities stood at $300000.0 in 2018, then skyrocketed by 1133.33% to $3.7 million in 2019, then increased by 29.73% to $4.8 million in 2020, then grew by 27.08% to $6.1 million in 2021, then plummeted by 140.28% to -$2.5 million in 2022.
  • Business Quant data shows Other financing activities for TECH at -$2.5 million in Q3 2022, $3.4 million in Q1 2022, and $6.1 million in Q4 2021.